Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$97.5M Buy
1,219,548
+191,537
+19% +$14.4M 0.07% 272
2014
Q2
$72.9M Buy
1,028,011
+58,312
+6% +$4.1M 0.06% 324
2014
Q1
$71.8M Buy
969,699
+100,325
+12% +$7.57M 0.06% 297
2013
Q4
$68.2M Buy
869,374
+65,663
+8% +$5.14M 0.06% 303
2013
Q3
$59.4M Buy
803,711
+103,696
+15% +$7.64M 0.06% 293
2013
Q2
$53.2M Buy
+700,015
New +$45.9M 0.06% 300

Other funds holding CME

UBS's CME Position: Q3 2014 in Review

UBS increased its CME Group (CME) stake by 19% in Q3 2014, buying an estimated $14.4M and bringing the position to 1,219,548 shares worth $97.5M. The position accounts for 0.07% of the portfolio, ranked #272.

UBS first reported a position in CME in Q2 2013 and has held it in 6 quarters since. 543 funds tracked by Wall St. Rank hold CME as of Q3 2014.

  • UBS held 1,219,548 shares of CME Group worth $97.5M as of Q3 2014.
  • UBS bought 191,537 CME Group shares in Q3 2014, an estimated $14.4M.
  • CME Group made up 0.07% of UBS's portfolio in Q3 2014, its #272 holding.
  • UBS first reported a position in CME Group in Q2 2013 and has held it in 6 quarters since.
  • 543 funds tracked by Wall St. Rank held CME Group as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.